KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Halozyme Therapeutics (HALO) Treasury Shares: 2009-2024

Historic Treasury Shares for Halozyme Therapeutics (HALO) over the last 3 years, with Dec 2024 value amounting to $1.4 million.

  • Halozyme Therapeutics' Treasury Shares rose 22.77% to $1.4 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.4 million, marking a year-over-year increase of 22.77%. This contributed to the annual value of $1.4 million for FY2024, which is 22.77% up from last year.
  • Latest data reveals that Halozyme Therapeutics reported Treasury Shares of $1.4 million as of Q4 2024, which was down 92.68% from $19.1 million recorded in Q2 2024.
  • Over the past 5 years, Halozyme Therapeutics' Treasury Shares peaked at $19.1 million during Q2 2024, and registered a low of $88,307 during Q2 2020.
  • Moreover, its 3-year median value for Treasury Shares was $4.5 million (2022), whereas its average is $6.8 million.
  • Its Treasury Shares has fluctuated over the past 5 years, first skyrocketed by 1,074.93% in 2021, then slumped by 74.68% in 2023.
  • Over the past 5 years, Halozyme Therapeutics' Treasury Shares (Quarterly) stood at $6.5 million in 2020, then tumbled by 40.00% to $3.9 million in 2021, then rose by 15.38% to $4.5 million in 2022, then crashed by 74.68% to $1.1 million in 2023, then increased by 22.77% to $1.4 million in 2024.
  • Its Treasury Shares was $1.4 million in Q4 2024, compared to $19.1 million in Q2 2024 and $12.6 million in Q1 2024.